A detailed history of Wcm Investment Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Wcm Investment Management, LLC holds 16,945 shares of BMRN stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,945
Previous 6,460 162.31%
Holding current value
$1.13 Million
Previous $531,000 124.29%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$69.02 - $93.84 $723,674 - $983,912
10,485 Added 162.31%
16,945 $1.19 Million
Q2 2024

Jul 31, 2024

BUY
$74.43 - $92.22 $118,566 - $146,906
1,593 Added 32.73%
6,460 $531,000
Q1 2024

Apr 25, 2024

BUY
$83.81 - $99.0 $6,369 - $7,524
76 Added 1.59%
4,867 $425,000
Q4 2023

Jan 29, 2024

BUY
$76.22 - $98.51 $365,170 - $471,961
4,791 New
4,791 $461,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.